Bergamot Albedo Phytocomplex Extraction for Toxicity Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bergamot essential oil extracts pose toxicity risks due to the presence of furocumarines like bergaptene, limiting their safe use, and existing methods for extracting bioflavonoids do not effectively address metabolic and glycemic issues or skin inflammation.
Innovation Solution
A process involving the extraction and purification of a phytocomplex from bergamot fruit albedo, specifically reducing furocumarine content through enzymatic degradation, ultrafiltration, and chemical stabilization, resulting in a dry extract with enhanced healing properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bergamot essential oil extracts are used for their therapeutic properties, then healing action is achieved, but toxicity occurs due to furocumarines like bergaptene
Solution Approach 1:
The patent extracts and removes furocumarines (bergaptene and bergamottine) from the bergamot fruit albedo through a multi-step process involving enzymatic treatment with pectolytic enzymes, ultrafiltration, and chemical stabilization, while preserving the beneficial polyphenolic fraction including bioflavonoids
Solution Approach 2:
The patent utilizes the albedo (white membrane) from bergamot fruit, which is normally a waste product from essential oil extraction, and converts it into a valuable therapeutic product by extracting its polyphenolic content while removing toxic furocumarines, thus transforming a discarded material into a beneficial phytocomplex
2Quantity of substance
If traditional extraction methods are used for bioflavonoids, then extraction is achieved, but metabolic and glycemic issues are not addressed
Solution Approach 1:
The patent creates a multi-functional phytocomplex from bergamot albedo that simultaneously addresses multiple health concerns: it controls cholesterol levels, regulates glycemia, provides antioxidant protection, and offers anti-inflammatory benefits, rather than targeting a single function
3Quantity of substance
If existing extraction processes are used, then bioflavonoids are obtained, but skin inflammation is not effectively treated
Solution Approach 1:
The patent employs parameter changes throughout the extraction and purification process, including pH adjustments during chemical stabilization, temperature control during enzymatic treatment, and molecular weight cutoff selection during ultrafiltration, to optimize both the quantity of bioflavonoids and their anti-inflammatory activity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting dry extract effectively normalizes cholesterol and glycemic levels, exhibits antioxidant and anti-inflammatory effects, and inhibits cell proliferation, with no toxic side effects, making it suitable for pharmaceutical and dietary supplement applications.
Implementation Method 1
enzymatic degradation
Implementation Method 2
ultrafiltration
Implementation Method 3
chemical stabilization
Data Source
AI summary
The invention relates a phytocomplex obtained from the bergamot fruit albedo (Citrus Bergamia Risso & Poiteau), the production thereof and the use thereof, in particular under the form of dry extract, to be used as normalizer of the metabolic unbalances of lypemic and glycemic type, in the treatment of the cutaneous diseases with inflammatory or degenerative character, as painkilling/anti- inflammatory agent, as antineoplastic agent and dietary supplement.